Biocept, Inc. (Nasdaq: BIOC) has announced a clinical research publication further validating its cancer-detecting liquid biopsy platform.
Moderna, Inc. (Nasdaq: MRNA) has announced the completion of enrollment for a Phase 2 study evaluating its cytomegalovirus vaccine.
By contributing to changes in metabolism, immunity, and neurophysiology, alterations in the gut microbiome influence developmental processes in the brain and are potentially involved in Autism Spectrum Disorder pathogenesis.
The presence of a white blood cell subpopulation was recently demonstrated to effectively distinguish individuals capable of naturally controlling HIV infection, known as HIV controllers, from people requiring antiviral medication.
A recent survey of Ulcerative Colitis patients and gastroenterologists in ten countries explored whether patients and physicians agree upon the importance of reasons for pursuing disease management and shed light on the perceptions of ulcerative colitis patients.
Lymph Vessel Network Important for Combatting Rheumatic Diseases, Potential Role for Alternative Medicine
New research and treatments for Rheumatic Diseases may focus on the lymphatic system and alternative medicine.
Possible Combination Treatment for Patients with Cancers not Responsive to Immune Checkpoint Inhibitors
A combination treatment involving a drug stimulating an innate immune receptor could render immune checkpoint inhibitors functional in patients with otherwise unresponsive cancers.
The expression level of the protein Interleukin-21 in circulating immune cells may serve as a biomarker for kidney transplant rejection.
Possible Combination Therapy for Sensitized Kidney Transplant Recipients Harnesses Existing Cancer Drug
A combinationm therapy involving an existing cancer drug and costimulation blockade has shown promise for sensitized kidney transplant recipients.